Upgrade to SI Premium - Free Trial

BioNTech SE (BNTX)

89.59 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/4/26)

Latest Headlines

Lilly cuts Germany investment plan in half over healthcare reforms June 3, 2026 1:17 PM - StreetInsider The Multi-Billion-Dollar Search for Better Glioblastoma Treatments June 3, 2026 9:29 AM - StreetInsider Form 6-K BioNTech SE For: Jun 01 June 1, 2026 8:00 AM - SEC Filing JPMorgan says large-cap biotech is back as profits and pipelines fuel upside May 28, 2026 4:07 PM - StreetInsider UBS Upgrades BioNTech (BNTX) to Buy May 27, 2026 4:21 AM - StreetInsider Form 6-K BioNTech SE For: May 22 May 22, 2026 8:03 AM - SEC Filing BioNTech to Showcase Progress Across Late-Stage Oncology Pipeline at the 2026 ASCO Annual Meeting May 22, 2026 5:00 AM - Globe NewsWire Bernstein SocGen Group Starts BioNTech (BNTX) at Market Perform May 21, 2026 4:24 PM - StreetInsider JPMorgan sees biotech sector at inflection point, resumes coverage on 14 Firms May 20, 2026 3:10 PM - StreetInsider JPMorgan Reinstates BioNTech (BNTX) at Neutral May 20, 2026 4:30 AM - StreetInsider Form 6-K BioNTech SE For: May 15 May 15, 2026 4:25 PM - SEC Filing BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2026 May 15, 2026 4:15 PM - Globe NewsWire Form SCHEDULE 13G/A BioNTech SE Filed by: Sahin Ugur May 15, 2026 4:07 PM - SEC Filing Form SCHEDULE 13G/A BioNTech SE Filed by: ATHOS KG May 14, 2026 5:23 PM - SEC Filing Form 4 BioNTech SE For: May 12 Filed by: Zapata Gomez Ramon May 13, 2026 4:09 PM - SEC Filing Form 4 BioNTech SE For: May 12 Filed by: Ryan James Timothy Patrick May 13, 2026 4:08 PM - SEC Filing Form 4 BioNTech SE For: May 12 Filed by: Poetting Sierk May 13, 2026 4:06 PM - SEC Filing Form 4 BioNTech SE For: May 12 Filed by: Jimenez Kylie May 13, 2026 4:04 PM - SEC Filing Form 4 BioNTech SE For: May 12 Filed by: Hanekamp Annemarie May 13, 2026 4:02 PM - SEC Filing Form 144 BioNTech SE Filed by: Medine GmbH May 12, 2026 6:57 PM - SEC Filing Form 6-K BioNTech SE For: May 07 May 7, 2026 8:20 AM - SEC Filing BioNTech authorizes $1 billion share repurchase program May 7, 2026 6:45 AM - StreetInsider BioNTech Announces New ADS Repurchase Program May 7, 2026 6:45 AM - Globe NewsWire BioNTech (BNTX) PT Lowered to $140 at Wells Fargo May 6, 2026 8:43 AM - StreetInsider BioNTech (BNTX) PT Lowered to $158 at Canaccord May 6, 2026 6:51 AM - StreetInsider BioNTech (BNTX) PT Lowered to $125 at BofA Securities May 5, 2026 12:07 PM - StreetInsider BioNTech SE (BNTX) Tops Q1 EPS by 20c, provides guidance May 5, 2026 6:56 AM - StreetInsider Form 6-K BioNTech SE For: Mar 31 May 5, 2026 6:50 AM - SEC Filing Form 6-K BioNTech SE For: May 05 May 5, 2026 6:48 AM - SEC Filing BioNTech Announces First Quarter 2026 Financial Results and Corporate Update May 5, 2026 6:45 AM - Globe NewsWire H.C. Wainwright Reiterates Buy Rating on BioNTech (BNTX) April 27, 2026 6:47 AM - StreetInsider Form 4 BioNTech SE For: Apr 22 Filed by: Poetting Sierk April 23, 2026 7:23 PM - SEC Filing BioNTech to Report First Quarter 2026 Financial Results and Corporate Update on May 5, 2026 April 21, 2026 6:45 AM - Globe NewsWire Form 3/A BioNTech SE For: Mar 18 Filed by: Sahin Ugur April 13, 2026 4:02 PM - SEC Filing Form 6-K BioNTech SE For: Apr 13 April 13, 2026 7:56 AM - SEC Filing BioNTech (BNTX) PT Raised to $130 at BofA Securities April 13, 2026 5:13 AM - StreetInsider BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer April 11, 2026 7:00 AM - Globe NewsWire BioNTech (BNTX) PT Raised to $126 at Morgan Stanley April 10, 2026 8:15 AM - StreetInsider BioNTech (BNTX) PT Lowered to $94 at Leerink Partners April 7, 2026 6:21 AM - StreetInsider Form 6-K BioNTech SE For: Apr 02 April 2, 2026 4:16 PM - SEC Filing Form 20-F/A BioNTech SE For: Dec 31 April 1, 2026 4:16 PM - SEC Filing Exclusive-Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles April 1, 2026 12:16 PM - StreetInsider BioNTech (BNTX) PT Lowered to $130 at H.C. Wainwright March 31, 2026 6:38 AM - StreetInsider Form 3 BioNTech SE For: Mar 18 Filed by: Blackwood Nicola Claire March 25, 2026 6:05 PM - SEC Filing Form 3 BioNTech SE For: Mar 18 Filed by: Morawietz Anja March 25, 2026 6:03 PM - SEC Filing Form 3 BioNTech SE For: Mar 18 Filed by: Staudigl Rudolf March 25, 2026 6:02 PM - SEC Filing Form 3 BioNTech SE For: Mar 18 Filed by: Sahin Ugur March 25, 2026 6:00 PM - SEC Filing Form 3 BioNTech SE For: Mar 18 Filed by: Zapata Gomez Ramon March 25, 2026 5:58 PM - SEC Filing Form 3 BioNTech SE For: Mar 18 Filed by: Ryan James Timothy Patrick March 25, 2026 5:57 PM - SEC Filing Form 3 BioNTech SE For: Mar 18 Filed by: Jimenez Kylie March 25, 2026 5:55 PM - SEC Filing Form 6-K BioNTech SE For: Mar 24 March 24, 2026 5:10 PM - SEC Filing Form 3 BioNTech SE For: Mar 18 Filed by: Motschmann Michael March 18, 2026 5:43 PM - SEC Filing Form 3 BioNTech SE For: Mar 18 Filed by: Poetting Sierk March 18, 2026 5:41 PM - SEC Filing Form 3 BioNTech SE For: Mar 18 Filed by: Jeggle Helmut Wolfgang March 18, 2026 5:39 PM - SEC Filing Form 3 BioNTech SE For: Mar 18 Filed by: Tureci Ozlem March 18, 2026 5:36 PM - SEC Filing Form 3 BioNTech SE For: Mar 18 Filed by: Wandschneider Ulrich March 18, 2026 5:34 PM - SEC Filing Form 3 BioNTech SE For: Mar 18 Filed by: Hanekamp Annemarie March 18, 2026 5:31 PM - SEC Filing US Judge blocks Trump Admin cuts to number of routinely recommended vaccines for children - Reuters March 16, 2026 3:46 PM - StreetInsider BioNTech (BNTX) PT Lowered to $94 at TD Cowen March 11, 2026 9:23 AM - StreetInsider BioNTech (BNTX) PT Lowered to $128 at BMO Capital March 11, 2026 9:15 AM - StreetInsider Form 144 BioNTech SE Filed by: Poetting Sierk March 11, 2026 8:03 AM - SEC Filing US vaccine advisers drop plan to question mRNA COVID shots, WaPo reports March 11, 2026 6:32 AM - StreetInsider BioNTech (BNTX) PT Lowered to $130 at Citi March 11, 2026 5:00 AM - StreetInsider Oppenheimer Reiterates Perform Rating on BioNTech (BNTX) following management changes March 10, 2026 5:14 PM - StreetInsider BioNTech (BNTX) PT Lowered to $167 at Clear Street: "absurd to be trading near cash" March 10, 2026 4:05 PM - StreetInsider BioNTech (BNTX) PT Lowered to $138 at Jefferies March 10, 2026 3:41 PM - StreetInsider BioNTech SE (BNTX) June 80 and September 55 puts active as share price down 17.7% March 10, 2026 3:14 PM - StreetInsider Truist Securities Reiterates Buy Rating on BioNTech (BNTX) following earnings, management changes March 10, 2026 2:28 PM - StreetInsider BioNTech (BNTX) PT Lowered to $128 at BofA Securities March 10, 2026 12:29 PM - StreetInsider Morgan Stanley Reiterates Overweight Rating on BioNTech (BNTX): "timing of announcement likely driving weakness in stock" March 10, 2026 12:06 PM - StreetInsider Form 20-F BioNTech SE For: Dec 31 March 10, 2026 6:57 AM - SEC Filing Form 6-K BioNTech SE For: Mar 10 March 10, 2026 6:54 AM - SEC Filing Form 6-K BioNTech SE For: Mar 10 March 10, 2026 6:35 AM - SEC Filing BioNTech co-founders to establish new mRNA company by 2026 March 10, 2026 6:34 AM - StreetInsider BioNTech and Co-Founders Announce Plan to Pursue Next-Generation mRNA Innovations in Co-Founders-Led New Company as BioNTech Advances Toward Becoming a Multi-Product Company by 2030 March 10, 2026 6:33 AM - Globe NewsWire Full Article List